Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47
Journal of Clinical Investigation · 17.01.2023 · 133 (2)
DOI: 10.1172/jci153470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.01.2023. Verfasst von Huanhuan Hu und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Instit…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), School of Life Sciences, and.
- Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, China.
- Cancer Stem Cell Laboratory, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
- Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Re…
- Research Unit of Extracellular RNA, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, China.
- Institute of Artificial Intelligence Biomedicine, Nanjing University, Nanjing, China.
Förderung
- National Natural Science Foundation of China
- Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Hu, H., Cheng, R., Wang, Y., Wang, X., Wu, J., Kong, Y., Zhan, S., Zhou, Z., Zhu, H., Yu, R., Liang, G., Wang, Q., Zhu, X., Zhang, C. Y., Yin, R., Yan, C., & Chen, X. (2023). Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. Journal of Clinical Investigation, 133(2). https://doi.org/10.1172/jci153470
Vancouver
Hu H, Cheng R, Wang Y, Wang X, Wu J, Kong Y, et al. Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. Journal of Clinical Investigation. 2023;133(2). doi:10.1172/jci153470
BibTeX
@article{Hu2023,
author = {Hu, Huanhuan and Cheng, Rongjie and Wang, Yanbo and Wang, Xiaojun and Wu, Jianzhuang and Kong, Yan and Zhan, Shoubin and Zhou, Zhen and Zhu, Hongyu and Yu, Ranran and Liang, Gaoli and Wang, Qingyan and Zhu, Xiaoju and Zhang, Chen-Yu and Yin, Rong and Yan, Chao and Chen, Xi},
title = {Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {2},
doi = {10.1172/jci153470}
}
EUVIMED